Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
N4-Acetyl-Sulfamethoxazole Bladder Stones Caused by Trimethoprim-Sulfamethoxazole Prophylaxis: A Report of Two Cases.
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
Ionizable Lipid-Dependent Optimization of Steroid Lipid Nanoparticles With Tunable Immunomodulatory Properties.
Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis.
The gut microbiome plays a modifiable role in MS progression-No.
Dose-Dependent Effects of Minocycline on Facial Nerve Regeneration: A Microscopic and Molecular Study.
Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study.
Increased exertion variability is linked to disruptions in effort assessment in multiple sclerosis.
Interleukin-6 trans-signalling as a selectively targetable driver of neurodegeneration.
Nonsystemic Vasculitic Neuropathy Presenting as Inflammatory Demyelinating Polyradiculoneuropathy.
Staying afloat with OCEAN traits: The five-factor model of personality and psychological resilience in multiple sclerosis.
[Practice of obstetric medicine in neurological disorders: towards evidence-based shared decision-making (SDM)].
Neurofascin Antibodies in a Large Cohort of Inflammatory Neuropathies from India.
Eculizumab treatment in the salvage therapy of MOGAD: a case report.
Ocular adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database.
Exosome-based nanomedicine for neurological disorders: mechanisms, engineering, and therapeutic potential.
Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Prevalence of neuromyelitis optica spectrum disorder in Fujian, China, 2021-2023: a population-based study.
Fabrication and Biocompatibility Testing of Thin-Film Metamaterial Neurostimulation Leads for Magnetic Resonance Imaging.
Effect of external versus internal focus of attention instructions on gait performance in people with multiple sclerosis.
Profiling miRNAs Involved in Human Oligodendrocyte Precursor Cell Differentiation and Maturation.
Cerebrospinal fluid/plasma albumin quotient in dementia: a systematic review of biomarker potential and clinical associations.
Long-term outcomes of childhood encephalitis in Australia: burden and predictors from the Australian childhood encephalitis (ACE) prospective multicentre cohort.
Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.
Pages
« first
‹ previous
…
1065
1066
1067
1068
1069
1070
1071
1072
1073
…
next ›
last »